JiangXi Tianxin Pharm Co Ltd (603235) — Capital Reinvestment Ratio
JiangXi Tianxin Pharm Co Ltd (603235) has a Capital Reinvestment Ratio of 0.92x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥629.36 Million) in capital expenditures (CN¥580.68 Million). See how much free cash does JiangXi Tianxin Pharm Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
JiangXi Tianxin Pharm Co Ltd Capital Reinvestment Ratio (2020–2025)
This chart tracks JiangXi Tianxin Pharm Co Ltd's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for JiangXi Tianxin Pharm Co Ltd (2020–2025)
Year-by-year Capital Reinvestment Ratio for JiangXi Tianxin Pharm Co Ltd from 2020 to 2025. For live market cap and broader valuation context, see JiangXi Tianxin Pharm Co Ltd (603235) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.92x | CN¥629.36 Million | CN¥580.68 Million | ▼ -56.8% |
| 2024 | 2.14x | CN¥499.66 Million | CN¥1.07 Billion | ▲ +190.7% |
| 2023 | 0.73x | CN¥729.21 Million | CN¥535.60 Million | ▲ +71.0% |
| 2022 | 0.43x | CN¥606.61 Million | CN¥260.50 Million | ▲ +63.1% |
| 2021 | 0.26x | CN¥818.63 Million | CN¥215.50 Million | ▲ +1.1% |
| 2020 | 0.26x | CN¥1.16 Billion | CN¥303.04 Million | — |